Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 147Leukemia, Lymphocytic, Chronic, B-Cell 140Lymphoma 116Lymphoma, Non-Hodgkin 112Leukemia, Myeloid, Acute 95Leukemia 92Myelodysplastic Syndromes 90Hodgkin Disease 68Lymphoma, B-Cell 61Leukemia, Myelogenous, Chronic, BCR-ABL Positive 53Multiple Myeloma 52Lymphoma, Mantle-Cell 52Lymphoma, Large B-Cell, Diffuse 50Lymphoma, Follicular 50Recurrence 43Burkitt Lymphoma 41Hematologic Neoplasms 36Myeloproliferative Disorders 31Lymphoma, B-Cell, Marginal Zone 30Neoplasms, Plasma Cell 20Primary Myelofibrosis 19Leukemia, Biphenotypic, Acute 18Anemia, Refractory, with Excess of Blasts 18Lymphoma, T-Cell 17Leukemia, Myelomonocytic, Chronic 15Graft vs Host Disease 15Anemia, Aplastic 15Leukemia, Prolymphocytic 14Neoplasms 12Leukemia, B-Cell 12

Interventions

fludarabine phosphate 1fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Smooth Muscle Tumor × fludarabine × Lymphoid × Clear all
NCT02287311 2026-03-23

MABEL

Baylor College of Medicine

Phase 1 Active not recruiting
38 enrolled 16 charts
Head & NeckLymphoid

Nasopharyngeal Carcinoma, Hodgkin Disease, Lymphoma, Non-Hodgkin, Smooth Muscle Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡